Home › Trials › NCT06080464
Clinical trial Recruiting at 2 sites Interventional Ages 18 to 85

Clinician satisfaction with the VERABAND wearable activity monitor

Official title: A Study of Clinician Satisfaction and Likelihood of Clinical Adoption of the VERABAND™

Run by University of Michigan · NCT06080464 · Data updated 2026-11-12

This study will test whether giving wearable VERABAND activity monitors to people with chronic low back pain helps clinicians find the device usable and likely to use in patient care.

More Chronic Low-back Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 85 Years
SexAll
Enrollment360 (estimated)
SponsorUniversity of Michigan
Academic / other
Locations3 sites (La Jolla, California and 2 other locations)
StatusRecruiting
StartedJune 9, 2025
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedJune 3, 2026
Trial IDNCT06080464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are ambulatory adults with chronic low back pain that interferes with mobility who are starting a new non-surgical treatment and are willing to wear and return a disposable VERABAND until their next clinic visit.

Probably not a fit

Patients who are non-ambulatory, have signs of systemic disease, are not starting a new non-surgical treatment, or are unwilling to wear or return the device are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Up to 340 ambulatory patients with chronic low back pain will receive a disposable VERABAND activity monitor at baseline and begin a new non-surgical treatment as part of routine care. Activity data and weekly summary reports will be sent to the treating clinician before each follow-up visit across multiple tertiary pain clinics. Twenty clinicians will complete a usability satisfaction survey at the end of each patient's episode of care, and the primary outcome is clinician-reported usability and likelihood of clinical adoption. Exploratory analyses will examine whether clinician perceptions differ by patient phenotype such as pain severity, disability, or psychological characteristics.

Why it matters

Potential benefit: If successful, clinicians might use VERABAND to monitor patient activity between visits and better tailor treatments for chronic low back pain.

How similar studies have gone: Wearable activity monitors have been used successfully to track mobility in musculoskeletal conditions, but clinician satisfaction and adoption of a new disposable device like VERABAND remains relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Any treating clinician at a recruiting tertiary pain clinic will be eligible to participate.

Patient participants must meet the following criteria:

Inclusion Criteria:

* Ambulatory
* Diagnosis of chronic low back pain (cLBP) according to the criteria of National Institute of Health (NIH) Task Force on Research Standards for cLBP
* Answering 'Yes' to the question: Does your low back pain interfere with your mobility?
* Starting any new non-surgical treatment or combination of treatments for cLBP as part of their normal ongoing care, including medications; physical therapy/exercise; integrated therapies (e.g., massage, acupuncture, yoga); cognitive- behavioral therapy; and/or interventional procedures (e.g., epidural steroid or facet joint injections)
* Willingness to wear a VERABAND™ continuously until their next clinic visit and return used devices in the mail.

Exclusion Criteria:

* Clinical findings suggesting the presence of ongoing systemic disease, including fever, weight loss, initiation of pain following major trauma, immunosuppression, intravenous drug use, recent bacterial infection, severe or persistent sensory or motor involvement of bowel, bladder, or lower extremity; or any condition that would greatly limit physical activity not due to pain.
* Inability to speak and write English.
* Visual or hearing difficulties that would preclude participation.
* Severe psychiatric disorders that in the opinion of the investigative team would interfere with participation in the study. This includes any active suicidal ideations or history of suicide attempts. Exclusions will be based on self-reported medical history or chart review and in accordance with Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 criteria.
* Individuals receiving disability or compensation or involved in litigation.
* Scheduled surgery before follow-up.

Where it's running

  • University of Kansas Medical Center
    Kansas City, Kansas, United States     Recruiting
  • University of Michigan
    Ann Arbor, Michigan, United States     Recruiting
  • Altman Clinical and Translational Research Institute
    La Jolla, California, United States     Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Chronic Low-back Pain 131University of Michigan 165
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.